Exhibit 99.2
JOINT FILING AGREEMENT
In accordance with Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of an Amendment No. 1 to Schedule 13D (including additional amendments thereto) with respect to the shares of Common Stock, $0.001 par value, of Catalyst Bioscience, Inc., a Delaware corporation. This Joint Filing Agreement shall be filed as an Exhibit to such statement.
Dated: July 1, 2022
JEC II Associates, LLC | ||
By: | /s/ Michael Torok | |
Name: | Michael Torok | |
Title: | Manager |
The Heidi S. Shippell-Heiland 2008 Irrevocable Trust | ||
By: | /s/ Michael Torok | |
Name: | Michael Torok | |
Title: | Trustee | |
/s/ Michael Torok | ||
Michael Torok |